Open randomized clinical study evaluating preventive treatment with doxycycline on the occurrence of folliculitis rash during treatment with erlotinib in patients with locally advanced or metastatic non-small cell lung cancer who have relapsed after first line chemotherapy.

Trial Profile

Open randomized clinical study evaluating preventive treatment with doxycycline on the occurrence of folliculitis rash during treatment with erlotinib in patients with locally advanced or metastatic non-small cell lung cancer who have relapsed after first line chemotherapy.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Jan 2012

At a glance

  • Drugs Doxycycline; Erlotinib
  • Indications Bacterial infections; Folliculitis; Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms CYTAR
  • Sponsors Roche
  • Most Recent Events

    • 04 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top